BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16765378)

  • 41. Everyday cognitive failures and memory problems in Parkinson's patients without dementia.
    Poliakoff E; Smith-Spark JH
    Brain Cogn; 2008 Aug; 67(3):340-50. PubMed ID: 18358582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Don't look now or look away: two sources of saccadic disinhibition in Parkinson's disease?
    van Stockum S; MacAskill M; Anderson T; Dalrymple-Alford J
    Neuropsychologia; 2008 Nov; 46(13):3108-15. PubMed ID: 18674551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Executive functions deficit in mild cognitive impairment.
    Traykov L; Raoux N; Latour F; Gallo L; Hanon O; Baudic S; Bayle C; Wenisch E; Remy P; Rigaud AS
    Cogn Behav Neurol; 2007 Dec; 20(4):219-24. PubMed ID: 18091070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Slowing of information processing in Parkinson's disease.
    Revonsuo A; Portin R; Koivikko L; Rinne JO; Rinne UK
    Brain Cogn; 1993 Jan; 21(1):87-110. PubMed ID: 8424865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive dysfunctions in mild Parkinson's disease dementia: comparison with patients having mild Alzheimer's disease and normal controls.
    Song IU; Kim JS; Yoo JY; Song HJ; Lee KS
    Eur Neurol; 2008; 59(1-2):49-54. PubMed ID: 17917458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Depression predicts the pattern of cognitive impairment in early Parkinson's disease.
    Stefanova E; Potrebic A; Ziropadja L; Maric J; Ribaric I; Kostic VS
    J Neurol Sci; 2006 Oct; 248(1-2):131-7. PubMed ID: 16780884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparison of neuropsychological performance according to the age of onset in subjects with Parkinson's disease and Parkinsonism].
    Ruiz-Rizzo AL; Tirado V; Moreno-Carrillo C; Aguirre-Acevedo DC; Murillo O; Lopera F
    Rev Neurol; 2009 Aug 1-15; 49(3):123-30. PubMed ID: 19621306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
    Imamura K; Wada-Isoe K; Kitayama M; Nakashima K
    Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive training in MS: effects and relation to brain atrophy.
    Hildebrandt H; Lanz M; Hahn HK; Hoffmann E; Schwarze B; Schwendemann G; Kraus JA
    Restor Neurol Neurosci; 2007; 25(1):33-43. PubMed ID: 17473394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early cognitive changes and nondementing behavioral abnormalities in Parkinson's disease.
    Levin BE; Katzen HL
    Adv Neurol; 2005; 96():84-94. PubMed ID: 16383214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis.
    York MK; Lai EC; Jankovic J; Macias A; Atassi F; Levin HS; Grossman RG
    Acta Neurochir (Wien); 2007; 149(9):857-66; discussion 866. PubMed ID: 17624489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Executive function, mentalizing and humor in major depression.
    Uekermann J; Channon S; Lehmkämper C; Abdel-Hamid M; Vollmoeller W; Daum I
    J Int Neuropsychol Soc; 2008 Jan; 14(1):55-62. PubMed ID: 18078531
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The effect of age on executive functioning after acquired brain injury in adults].
    Chevignard M; Taillefer C; Poncet F; Picq C; Pradat-Diehl P
    Rev Neurol (Paris); 2008 Dec; 164(12):1018-27. PubMed ID: 18808778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
    Dalaker TO; Larsen JP; Dwyer MG; Aarsland D; Beyer MK; Alves G; Bronnick K; Tysnes OB; Zivadinov R
    Neuroimage; 2009 Oct; 47(4):2083-9. PubMed ID: 19539037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complaints about impairments in executive functions in Parkinson's disease: the association with neuropsychological assessment.
    Koerts J; van Beilen M; Leenders KL; Brouwer WH; Tucha L; Tucha O
    Parkinsonism Relat Disord; 2012 Feb; 18(2):194-7. PubMed ID: 22005327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The differential impact of executive attention dysfunction on episodic memory in obsessive-compulsive disorder patients with checking symptoms vs. those with washing symptoms.
    Omori IM; Murata Y; Yamanishi T; Nakaaki S; Akechi T; Mikuni M; Furukawa TA
    J Psychiatr Res; 2007 Nov; 41(9):776-84. PubMed ID: 16824544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of effect of cognitive intervention programs for the community-dwelling elderly with subjective memory complaints.
    Tsai AY; Yang MJ; Lan CF; Chen CS
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1172-4. PubMed ID: 18496884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial.
    Gehring K; Sitskoorn MM; Gundy CM; Sikkes SA; Klein M; Postma TJ; van den Bent MJ; Beute GN; Enting RH; Kappelle AC; Boogerd W; Veninga T; Twijnstra A; Boerman DH; Taphoorn MJ; Aaronson NK
    J Clin Oncol; 2009 Aug; 27(22):3712-22. PubMed ID: 19470928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Demonstration of cognitive decline in Parkinson's disease using the Cambridge Cognitive Assessment (Revised) (CAMCOG-R).
    Athey RJ; Walker RW
    Int J Geriatr Psychiatry; 2006 Oct; 21(10):977-82. PubMed ID: 16955442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.